- This event has passed.
Myonexus Therapeutics: 0 to >$200 Million in Less than Three Years
January 10, 2020 @ 11:30 am - 1:00 pm
Dr. Triplett will share the story of how Myonexus Therapeutics was formed and quickly achieved a $200+ million exit in less than three years. Attendees will learn about Columbus’ life sciences innovation strengths and how the Columbus Region can build upon Myonexus and other successes to create a sustainable, larger life sciences venture and innovation ecosystem.
Dr. Michael Triplett is a co-founder and Managing Member of 1787 Bio, LLC, a life sciences investment organization based in Columbus, Ohio, and President of Carmen Partners LLC, a life science ventures, commercialization, and innovation consultancy. Dr. Triplett co-founded and served as President and CEO of Myonexus Therapeutics, a clinical stage gene therapy company developing first-ever treatments for limb-girdle muscular dystrophies. Sarepta Therapeutics (SRPT) acquired Myonexus Therapeutics for >$225 million in April 2019.
Dr. Triplett began his career at Procter & Gamble as a Product Development Engineer prior to attending graduate school. After completing his graduate work in nanoparticle engineering as a U.S. Department of Defense National Defense Science and Engineering Graduate Fellow, he joined Battelle where he held roles of progressing responsibility, spanning business development, innovation, new venture development, corporate ventures, and strategy for the Health & Life Sciences Global Business. Prior to co-founding Myonexus Therapeutics, Dr. Triplett served as Chief Executive Officer of N8 Medical, a clinical stage combination device company with Breakthrough designation for its lead antimicrobial endotracheal tube product.
Excelling at the interfaces of business and innovation, Dr. Triplett is passionate about translating world-class science and technology into transformative businesses, products, and capabilities that enhance human health, American competitiveness, and economic opportunity. Dr. Triplett focuses on life sciences technology ventures, innovation, technology-based economic development, and science, technology, engineering and math (STEM) education.
Dr. Triplett is currently leading an InnovateOhio Life Sciences Working Group for Ohio Lieutenant Governor Jon Husted with the mission to propose life sciences specific economic development strategies for the State of Ohio.
Dr. Triplett received his B.S. in Chemical Engineering (summa cum laude) and Ph.D. in Chemical Engineering from The Ohio State University.
Event is free and includes a light lunch.
11:30am – Networking & lunch
12:00pm – Program begins
1:00pm – Networking resumes
Thank you to our sponsor Mmelo Boutique Confections.
This event has passed so registration is closed.